Unknown

Dataset Information

0

Design and Characterization of Novel Small Molecule Activators of Excitatory Amino Acid Transporter 2.


ABSTRACT: Excitotoxicity in the brain is a causal factor in several neurological and neurodegenerative disorders. Excitatory amino acid transporter 2 (EAAT2), an astrocytic glutamate transporter involved in the clearance of >80% of synaptic glutamate, is considered a therapeutically relevant target for excitotoxicity. We have previously designed GT951, an activator of EAAT2 with nanomolar efficacy but limited in vivo bioavailability. In this study, a pharmacophore-based screening and optimization resulted in the design of GTS467 and GTS511. GTS467 and GTS511 have low nanomolar efficacy in the glutamate uptake assay. Pharmacokinetic profiles (PK) of GTS511 show a >6 h half-life and higher bioavailability in plasma and the brain under all three routes of administration in rats. Similarly, GTS467 has high oral bioavailability (80-85%) in the brain and plasma with a >1 h half-life under all three dosing routes. These encouraging efficacy and PK profiles suggest that GTS511 and GTS467 can be further developed to treat neurological disorders caused by excitotoxicity.

SUBMITTER: Das S 

PROVIDER: S-EPMC9575181 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Design and Characterization of Novel Small Molecule Activators of Excitatory Amino Acid Transporter 2.

Das Sanjay S   Trubnikov Artem V AV   Novoselov Anton M AM   Kurkin Alexander V AV   Beld Joris J   Altieri Andrea A   Kortagere Sandhya S  

ACS medicinal chemistry letters 20220919 10


Excitotoxicity in the brain is a causal factor in several neurological and neurodegenerative disorders. Excitatory amino acid transporter 2 (EAAT2), an astrocytic glutamate transporter involved in the clearance of >80% of synaptic glutamate, is considered a therapeutically relevant target for excitotoxicity. We have previously designed GT951, an activator of EAAT2 with nanomolar efficacy but limited in vivo bioavailability. In this study, a pharmacophore-based screening and optimization resulted  ...[more]

Similar Datasets

| S-EPMC6139576 | biostudies-literature
| S-EPMC4969196 | biostudies-literature
| S-EPMC5410168 | biostudies-literature
| S-EPMC9725111 | biostudies-literature
| S-EPMC8141794 | biostudies-literature
| S-EPMC20584 | biostudies-literature
| S-EPMC3683608 | biostudies-literature
| S-EPMC11398500 | biostudies-literature
| S-EPMC4356123 | biostudies-literature
2023-06-14 | GSE217059 | GEO